Cellectar Biosciences Inc. 计划在即将于第44届摩根大通医疗健康大会期间举办的生物技术展示会上,重点阐述其2026年的战略举措。
Cellectar Biosciences Inc. 计划在即将于第44届摩根大通医疗健康大会期间举办的生物技术展示会上,重点阐述其2026年的战略举措。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.